Welcome to our dedicated page for 22Nd Century SEC filings (Ticker: XXII), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how a plant-biotech tobacco company navigates the SEC can feel like decoding a laboratory notebook. 22nd Century Group’s filings blend patent disclosures on genetically engineered nicotine plants, FDA correspondence on its VLN® cigarette, and capacity updates from its Mocksville facility—details that sprawl across a 10-K well over 300 pages. If you have ever searched �22nd Century Group SEC filings explained simply� or needed �22nd Century Group 8-K material events explained,� you know the challenge: crucial datapoints hide behind dense regulatory language.
Stock Titan solves that problem. Our AI dissects every 22nd Century Group quarterly earnings report 10-Q filing, highlights unit sales for reduced-nicotine cigarettes, and flags R&D spending in seconds. Interactive dashboards turn the annual report into �22nd Century Group annual report 10-K simplified,� while sentence-level summaries offer �22nd Century Group earnings report filing analysis� you can skim during a coffee break. By understanding 22nd Century Group SEC documents with AI, investors quickly spot FDA milestones, cash burn trends, or new contract-manufacturing revenue without scrolling through footnotes.
Need to monitor executive incentives or potential signals from insiders? Receive instant alerts on �22nd Century Group insider trading Form 4 transactions� and review �22nd Century Group Form 4 insider transactions real-time.� Our coverage links each trade to the appropriate �22nd Century Group executive stock transactions Form 4� so you can correlate buying or selling with fresh disclosures. Proxy tools clarify �22nd Century Group proxy statement executive compensation,� and real-time feeds ensure no filing�10-K, 10-Q, 8-K, or S-3—escapes your radar. Complex biotech-tobacco filings, delivered in plain English and updated the moment EDGAR releases them.
22nd Century Group, Inc. prospectus supplement excerpts describe an offering and summarize product and corporate milestones. The company notes it received FDA authorization in December 2021 to market a combustible cigarette (VLN®) as a Modified Risk Tobacco Product using certain reduced nicotine exposure claims. VLN® began a pilot launch in April 2022 at select Circle K stores in and around Chicago and expanded with a phased rollout in 2023 to a footprint of more than 5,000 stores in 26 states. The prospectus shows offering economics including a per-share/underlying price and pro forma net tangible book value per share of $(0.0002). Placement agent fees are shown as $639,000 and gross proceeds before expenses as $10,011,000. The document also lists prospectus sections and related filing dates and exhibits referenced in the form.
22nd Century Group, Inc. reporting persons led by Anson Funds Management LP disclose collective beneficial ownership of 602,654 shares, representing 4.9% of the outstanding common stock on a fully-diluted basis that includes shares issuable upon exercise of warrants. The filing shows no sole voting or dispositive power by any single filer; voting and dispositive power are reported as shared for the full 602,654 shares. The ownership count is calculated using 11,507,622 outstanding shares plus 569,616 shares issuable on warrants, for a denominator of 12,077,238 shares. Reporting entities include Anson Funds Management LP, Anson Management GP LLC, Anson Advisors Inc., and named individuals Tony Moore, Amin Nathoo and Moez Kassam, with organizational places of Texas, the United States and Canada as stated.
22nd Century Group reporting persons Iroquois Capital Management LLC, Richard Abbe and Kimberly Page disclosed warrant positions that together are presented as potential claims on the company's common stock but are constrained by a contractual ownership limit. The filing shows reported warrants to purchase 195,703 shares held through Iroquois Master Fund and 362,447 shares held through ICIG, producing an aggregate reported amount of 558,150 shares for Richard Abbe and 195,703 shares for each of Iroquois Capital and Kimberly Page. The statements calculate ownership as 4.99% of a 500,331-share base when giving effect to a contractual 4.99% blocker that prevents exercise of warrants that would exceed that threshold. The filing notes that the cover-page counts show full exercise numbers without deducting the blocker and that actual beneficial ownership after applying the blocker is lower.
22nd Century Group, Inc. disclosed that it has issued an earnings release covering the quarter ended June 30, 2025 and furnished that release as Exhibit 99.1 to this Form 8-K. The filing identifies the disclosure under Item 2.02 (results of operations and financial condition) and lists the exhibit under Item 9.01(d).
The company states the information in this item is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly specified. The report is signed on behalf of the registrant by the Chief Financial Officer.
FAQ
What is the current stock price of 22Nd Century (XXII)?
What is the market cap of 22Nd Century (XXII)?
